Form 8-K - Current report:
SEC Accession No. 0001599901-25-000091
Filing Date
2025-04-29
Accepted
2025-04-29 16:00:43
Documents
15
Period of Report
2025-04-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K rna-20250425.htm   iXBRL 8-K 38276
2 EX-16.1 exhibit161.htm EX-16.1 995
6 exhibit161001.jpg GRAPHIC 51286
  Complete submission text file 0001599901-25-000091.txt   239410

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20250425.xsd EX-101.SCH 1812
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20250425_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20250425_pre.xml EX-101.PRE 13067
17 EXTRACTED XBRL INSTANCE DOCUMENT rna-20250425_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 25886942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)